209
Participants
Start Date
May 1, 2013
Primary Completion Date
December 23, 2016
Study Completion Date
February 28, 2017
FOLFOX6m
SIR-Spheres microspheres
Institut Jules Bordet, Brussels
Auckland University, Grafton
Gosford Hospital, Gosford
Southern Medical Day Care Centre, Wollongong
Border Medical Oncology Research Unit, Albury
University of Antwerp, Edegem
Western Hospital, Footscray
Box Hill Hospital, Box Hill
Maroondah Hospital, Ringwood East
Monash Medical Centre, Bentleigh East
South Eastern Hospital, Noble Park
Peninsula Oncology Centre, Frankston
CHU Sart Tilman, Liège
Royal Brisbane Hospital, Herston
Princess Alexandra Hospital, Woolloongabba
Gold Coast Health Services District, Southport
Regional Cancer Treatment Service, Palmerston North
Royal Adelaide Hospital, Adelaide
Royal Perth Hospital, Perth
Sir Charles Gairdner Hospital, Nedlands
Wellington Hospital, Newtown
St. John of God Murdoch Hospital, Murdoch
Hobart Hospital, Hobart
AZ Maria Middelaress, Ghent
Dunedin Hospital, Dunedin
OL Vrouw Ziekenhuis, Aalst
National Taiwan University Hospital, Taipei
Lenox Hill Hospital, New York
Montefiore Medical Center, The Bronx
Ospedale Regionale U. Parini, Aosta
Taipei Veterans General Hospital, Taipei
Ufficio Sperimentale Cliniche, Oncologia Medica di Carle, Ospendale Santa Croce e Carle di Cuneo, Cuneo
Vivantes Klinikum Neukolln Klinik fur Innere Medizin - Hamatologie und Onkologie, Berlin
Roswell Park Cancer Center, Buffalo
University of Pittsburgh Medical Center, Pittsburgh
University of Maryland Medical Center, Baltimore
Dipartimento di Oncologia, Ospendali Riuniti di Bergamo, Bergamo
West Virginia University Healthcare, Morgantown
Carolinas Medical Center, Charlotte
Hospital Universitario Puerta de Hierro Majadahonda, Madrid
Spartanburg Regional Healthcare / Gibbs Cancer Center, Spartanburg
Clinica Universidad de Navarra, Pamplona
Complejo Hospitalario de Navarra, Pamplona
Rambam Medical Center, Haifa
Orlando Health, Orlando
Memorial Healthcare, Pembroke Pines
CHU de Bordeaux - Hopital Saint Andre, Pessac
Centre Eugene Marquis, Rennes
Universitatsklinikum Marburg Klinik fur Hamatologie, Onkologie und Immunologie, Marburg
Hopital Albert Michallon - Grenoble, Grenoble
Schwerpunktpraxix fur Hamatologie und Onkologie, Magdeburg
Universitaetsklinikum Magdeburg, Klinik fur Radiologie und Nuklearmedizin, Magdeburg
Klinikum Magdeburg GmbH, Klinik fur Allgemein und Viszeralchirurgie, Magdeburg
A.O.U. die Bologna, Bologna
St. Franziskus Hospital Muenster, Münster
Aurora St. Luke's Medical Center, Milwaukee
U.O. Oncologia Medica II, Nuovo Ospendale Santa Chiara, Azienda Ospendaliero Universitaria Pisana, Presidio Ospendaliero di Cisanello, Pisa
Sheba Medical Center - Governmental Hospital - Oncology Division, Tel Litwinsky
Adventist Midwest Health, Hinsdale
University of Illinois Chicago, Chicago
TA Sourasky Medical Center, Oncology Department 6, Tel Aviv
Ochsner Clinic Foundation, New Orleans
SLK-Kliniken Heilbronn GmbH, Klinik fur Radiologie, Heilbronn
Hopital Europeen Georges Pompidou, Paris
Methodist Hospital Dallas, Dallas
Stadtisches Klinikum Karlsruheg GMBH Klinik fur Nuklearmedizin, Karlsruhe
CHU Amiens, Amiens
Klinikum der Universitat Munchen, Munich
Klinikum rechts der Isar der TU Munchen Medizinische Klinik II, München
St. Mark's Hospital, Salt Lake City
CHU de Poitiers, Pole regional de cancerologie, Poitiers
City of Hope, Duarte
Shaare-Zedek Medical Center, Jerusalem
Hadassah Medical Center, Jerusalem
Centre Hospitalier General de Longjumeau, Clichy
Hopital Beaujon, Clichy
National Cancer Centre Singapore, Singapore
Fletcher Allen Health Care, Burlington
Universiteits Ziekenhuis Gent - Dienst Digestieve Oncologie, Ghent
Instituto Portugues de Oncologia do Porto Francisco Gentil, E.P.E., Porto
Seoul National University Hospital, Seoul
Korea University Anam Hospital, Seoul
Seoul St. Mary's Hospital, Seoul
Lead Sponsor
Sirtex Medical
INDUSTRY